Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

May 31, 2018

Conditions
Cirrhosis
Interventions
DRUG

gadoxetic acid enhanced liver MRI

"Gadoxetic acid enhanced liver MRI is performed and the standard dose of contrast media (0.025mmol/kg) is administered intravenously at a rate of 1mL/sec. Before and after contrast media injection, T1 map sequence is performed to calculate hepatocyte fraction.~Routine MR sequences (T2WI, T1WI, dual-echo sequence, DWI, MR elastography) are performed according to clinical protocol in the institution."

DRUG

ICG R15

ICG R15 (Indocyanine green retention test) is performed within 3 days after gadoxetic acid liver MRI, according to clinical standard protocol.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

National Research Foundation of Korea

OTHER

lead

Seoul National University Hospital

OTHER

NCT02854371 - Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI | Biotech Hunter | Biotech Hunter